GT
ELV icon

Glenview Trust’s Elevance Health ELV Stock Holding History

Glenview Trust’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$579K Sell
1,498
-4
-0.3% -$1.48K 0.01% 356
2026
Q1 		$440K Sell
1,502
-76
-5% -$25K 0.01% 379
2025
Q4 		$553K Buy
1,578
+6
+0.4% +$2.03K 0.01% 355
2025
Q3 		$508K Sell
1,572
-47
-3% -$14.6K 0.01% 376
2025
Q2 		$630K Buy
1,619
+475
+42% +$191K 0.01% 342
2025
Q1 		$498K Buy
1,144
+106
+10% +$42.6K 0.01% 360
2024
Q4 		$383K Sell
1,038
-391
-27% -$164K 0.01% 387
2024
Q3 		$743K Sell
1,429
-29
-2% -$15.5K 0.01% 298
2024
Q2 		$790K Sell
1,458
-541
-27% -$286K 0.02% 278
2024
Q1 		$1.04M Sell
1,999
-54
-3% -$26.9K 0.02% 253
2023
Q4 		$968K Buy
2,053
+713
+53% +$330K 0.02% 249
2023
Q3 		$583K Buy
1,340
+148
+12% +$67.1K 0.02% 293
2023
Q2 		$530K Buy
1,192
+30
+3% +$13.8K 0.01% 309
2023
Q1 		$534K Buy
1,162
+283
+32% +$135K 0.02% 310
2022
Q4 		$451K Buy
879
+64
+8% +$32.5K 0.01% 316
2022
Q3 		$370K Sell
815
-13
-2% -$6.22K 0.01% 318
2022
Q2 		$400K Buy
828
+50
+6% +$24.7K 0.01% 318
2022
Q1 		$382K Buy
778
+104
+15% +$47.5K 0.01% 340
2021
Q4 		$312K Buy
674
+5
+0.7% +$2.1K 0.01% 357
2021
Q3 		$249K Sell
669
-39
-6% -$14.8K 0.01% 364
2021
Q2 		$270K Sell
708
-1,060
-60% -$405K 0.01% 362
2021
Q1 		$635K Buy
1,768
+1,061
+150% +$341K 0.03% 224
2020
Q4 		$227K Buy
+707
New +$217K 0.01% 322
2020
Q1 		– Sell
-668
Closed -$202K – 321
2019
Q4 		$202K Buy
+668
New +$184K 0.01% 337

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glenview Trust's ELV Position: Q2 2026 in Review

Glenview Trust reduced its Elevance Health (ELV) stake by 0.27% in Q2 2026, selling an estimated $1.48K and leaving 1,498 shares worth $579K. The position accounts for 0.01% of the portfolio, ranked #356.

Glenview Trust first reported a position in ELV in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.04M in Q1 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Glenview Trust held 1,498 shares of Elevance Health worth $579K as of Q2 2026.
  • Glenview Trust sold 4 Elevance Health shares in Q2 2026, an estimated $1.48K.
  • Elevance Health made up 0.01% of Glenview Trust's portfolio in Q2 2026, its #356 holding.
  • Glenview Trust first reported a position in Elevance Health in Q4 2019 and has held it in 24 quarters since.
  • Glenview Trust's Elevance Health position peaked at $1.04M in Q1 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.